用SMAC武装的性病毒疗法通过调节PANoptosis来增强PD1阻断的抗癌活性
Fanghui Chen1, Liwei Lang2, Jianqiang Yang1
1Department of Hematology and Medical Oncology, Emory University, 201 Dowman Dr, Atlanta, GA, 30322, USA.
Biomarker research
|January 9, 2025
概括
工程化瘤性病毒VSV-S增强了癌细胞死亡和头癌的免疫反应. 将VS-S与PD1阻断结合起来显示出协同作用的抗瘤效应,改善了HNSCC患者的治疗结果.
科学领域:
- 瘤治疗性病毒疗法
- 癌症免疫学 癌症免疫学
- 分子瘤学分子瘤学
背景情况:
- 瘤病毒 (OVs) 通过选择性向瘤细胞,显示出癌症治疗的前景.
- 基于OV的病毒疗法的有限疗效在癌症治疗中仍然是一个挑战.
研究的目的:
- 用SMAC/DIABLO基因 (VSV-S) 改造囊泡性口腔炎病毒 (VSV),以提高瘤性活性.
- 评估VSV-S在头部和部状细胞癌 (HNSCC) 模型中的治疗潜力,包括其与PD1阻断的结合.
主要方法:
- 通过将SMAC/DIABLO基因插入VSV.S中来产生VSV-S.
- 实验中使用了HNSCC细胞系和正位素小鼠模型.
- 方法包括显微镜,西式涂抹,ELISA,LC-MS,流细胞计和免疫组织化学.
主要成果:
- 通过caspase-1/GSDMD信号传递,VS-S过度表达SMAC增加了细胞亡,并在HNSCC细胞中触发了PANoptosis (烧亡,细胞亡和亡).
- VSV-S诱导的PANoptosis增强了CD8+T细胞的透和细胞毒性能力,增强了T细胞介导的抗瘤免疫力.
- VSV-S降低了HNSCC细胞中的PDL1水平,与PD1阻断的结合产生了更强大的抗瘤效应.
结论:
- 与PD1阻断相结合的VSV-S证明了HNSCC的协同治疗策略.
- 这些发现支持推进基于VSV的病毒疗法,以改善HNSCC患者的治疗结果.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.2K
07:04Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
236
相关概念视频
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:30Cancer Vaccines
337
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
337